Biohaven Pharmaceutical Holding (BHVN) PT Raised to $68 at JPMorgan
Tweet Send to a Friend
JPMorgan analyst Tessa Romero raised the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $68.00 (from $55.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
